Citadel Advisors’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39.1M Buy
599,078
+486,233
+431% +$36.1M 0.01% 1585
2025
Q4
$8.94M Sell
112,845
-1,442,798
-93% -$111M ﹤0.01% 3409
2025
Q3
$114M Buy
1,555,643
+803,417
+107% +$58.9M 0.02% 750
2025
Q2
$57M Buy
752,226
+455,475
+153% +$32.3M 0.01% 1140
2025
Q1
$22.6M Buy
296,751
+295,764
+29,966% +$22M ﹤0.01% 1910
2024
Q4
$65.2K Buy
+987
New +$69.1K ﹤0.01% 12068
2024
Q3
Sell
-54,872
Closed -$3.3M 15429
2024
Q2
$2.9M Sell
54,872
-224,918
-80% -$13.7M ﹤0.01% 4618
2024
Q1
$19.5M Buy
+279,790
New +$20.9M ﹤0.01% 2099

Other funds holding SOLV

Citadel Advisors's SOLV Position: Q1 2026 in Review

Citadel Advisors increased its Solventum (SOLV) stake by 431% in Q1 2026, buying an estimated $36.1M and bringing the position to 599,078 shares worth $39.1M. The position accounts for 0.01% of the portfolio, ranked #1585.

Citadel Advisors first reported a position in SOLV in Q1 2024 and has held it in 8 quarters since. The position peaked at $114M in Q3 2025. 877 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Citadel Advisors held 599,078 shares of Solventum worth $39.1M as of Q1 2026.
  • Citadel Advisors bought 486,233 Solventum shares in Q1 2026, an estimated $36.1M.
  • Solventum made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1585 holding.
  • Citadel Advisors first reported a position in Solventum in Q1 2024 and has held it in 8 quarters since.
  • Citadel Advisors's Solventum position peaked at $114M in Q3 2025.
  • 877 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.